Prophylaxis of VTE in women - during assisted reproductive techniques (Q37388712)

20 August 2017

1 reference

title

Prophylaxis of VTE in women - during assisted reproductive techniques (English)

1 reference

20 August 2017

1

1 reference

20 August 2017

publication date

1 January 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

123 Suppl 3

1 reference

20 August 2017

page(s)

S8-S15

1 reference

A review of upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Effect of in vitro fertilization treatment and subsequent pregnancy on the protein C pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Activated protein C resistance during in vitro fertilization treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Response of blood coagulation parameters to elevated endogenous 17 beta-estradiol levels induced by human menopausal gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Does ovarian stimulation for in-vitro fertilization induce a hypercoagulable state?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Hemostasis parameters during ovarian stimulation for in vitro fertilization: results of a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Coexistent hemoconcentration and hypoosmolality during superovulation and in severe ovarian hyperstimulation syndrome: a volume homeostasis paradox

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

In vitro platelet function in controlled ovarian hyperstimulation cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

The "ART" of thromboembolism: a review of assisted reproductive technology and thromboembolic complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Artificial reproductive technology and the risk of venous thromboembolic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Thrombophilia and the risk for venous thromboembolism during pregnancy, delivery, and puerperium

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Thrombotic risk during pregnancy: a population study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Venous thromboembolism during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Incidence of diagnosed deep vein thrombosis in the general population: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Subclavian vein thrombosis following IVF and ovarian hyperstimulation: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Need for an urgent ultrasound examination for neck lump

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Internal jugular vein thrombosis following mild ovarian hyperstimulation syndrome in women with factor V Leiden mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Jugular vein thrombosis with severe local and systemic inflammation in a woman with ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Catastrophic antiphospholipid syndrome related to severe ovarian hyperstimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

A late complication of thrombosis in internal jugular vein and subclavian vein in a pregnant woman with ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Thrombosis of subclavian and internal jugular veins following severe ovarian hyperstimulation syndrome: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Successful management of an extensive intracranial sinus thrombosis in a patient undergoing IVF: case report and review of literature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Aphasia: an early uncommon complication of ovarian stimulation without ovarian hyperstimulation syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Deep vein thrombosis during administration of HMG for ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

More on: the 'ART' behind the clot: solving the mystery

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Arterial thrombosis and the role of thrombophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

The potential role of heparin in assisted conception

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Inherited thrombophilia and in vitro fertilization implantation failure

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Increased rates of thrombophilia in women with repeated IVF failures

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Multiple thrombophilic gene mutations are risk factors for implantation failure

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization success.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Increased antiphospholipid antibody activity in in-vitro fertilization patients is not treatment-dependent but rather an inherent characteristic of the infertile state

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Autoantibodies and antisperm antibodies in sera and follicular fluids of infertile patients; relation to reproductive outcome after in-vitro fertilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Antiphospholipid antibodies in women having in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Midfollicular anticardiolipin and antiphosphatidylserine antibody titers do not correlate with in vitro fertilization outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

The antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Incidence of autoimmune antibodies in failed embryo transfer cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Autoimmune disorders: another possible cause for in-vitro fertilization and embryo transfer failure

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Antiphospholipid antibody prevalence in patients with IVF failure

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Diagnostic evaluation of women experiencing repeated in vitro fertilization failure

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Pregnancy: Antiphospholipid antibodies and human reproductive failure

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Thromboembolic events in pregnancy: pharmacological prophylaxis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Prevention and treatment of ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Internal jugular vein thrombosis: a late complication of ovarian hyperstimulation syndrome despite mini-dose heparin prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Internal jugular vein thrombosis after assisted conception therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Deep vein thrombosis followed by internal jugular vein thrombosis as a complication of in vitro fertilization in a woman heterozygous for the prothrombin 3' UTR and factor V Leiden mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Low molecular weight heparin in pregnancy: current issues

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Guidelines on oral anticoagulation: third edition

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Duration of anticoagulation following venous thromboembolism: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2809%2970127-6

7 January 2021

10.1016/S0049-3848(09)70127-6

Identifiers

DOI

1 reference

20 August 2017

1 reference